Skip to main content
. 2020 Sep 10;10:14906. doi: 10.1038/s41598-020-72023-5

Figure 1.

Figure 1

Inhibition of Aryl hydrocarbon receptor (AhR) activation and magnetic resonance imaging (MRI) acquisition (A) Schematic of trimethoxyflavone (TMF) treatment for AhR antagonism. (B) Protocol of AhR treatment and MRI acquisition during the follow-up period.